Jupiter touts Tshipi investment; wants to increase its minority stake in Tshipi
In announcing its 14.5% yielding first half 2019 dividend principally from its 49.9% interest in the Tsihpi manganese mine, Jupiter mines said it “aspires to be the ASX vehicle of choice for investors looking to achieve crude steel and evolving battery material exposure.” The company added: “Our primary focus remains to put substantial cash into the shareholders pocket every six months. We endeavor to deliver this by focusing on a simple growth strategy aimed at opportunistic sales expansion (Tshipi has a well-established infrastructure capable of delivering up to 5-million mtpy) and cost reductions at Tshipi. We will consider value-accretive options to increase our underlying stake in Tshipi as well as regional consolidation in the Kalahari basin.”
By alanpatrickryan
On Septembe
- Forums
- ASX - By Stock
- JMS
- Ann: Jupiter Declares 14.5% Yielding H1 2019 Dividend
Ann: Jupiter Declares 14.5% Yielding H1 2019 Dividend, page-24
-
- There are more pages in this discussion • 210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JMS (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.3¢ |
Change
-0.008(2.78%) |
Mkt cap ! $514.5M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 26.0¢ | $744.3K | 2.795M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 693578 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 482490 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 693579 | 0.260 |
19 | 909946 | 0.255 |
22 | 1296976 | 0.250 |
11 | 663357 | 0.245 |
12 | 555812 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 482490 | 31 |
0.270 | 507132 | 9 |
0.275 | 1647620 | 15 |
0.280 | 491706 | 11 |
0.285 | 650775 | 12 |
Last trade - 14.47pm 15/07/2024 (20 minute delay) ? |
Featured News
JMS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online